Navigation Links
Study shows pine bark naturally relieves symptoms of acute hemorrhoids
Date:1/11/2010

(Jan. 12, 2009) HOBOKEN, NJ According to the National Digestive Diseases Information Clearinghouse, about half of the U.S. population will have hemorrhoids by the age of 50. While the most common prescription to treat hemorrhoids is over-the-counter remedies, most patients do not report symptoms of acute hemorrhoidal attacks to their doctor until they are in severe distress, including bleeding. A study published in a recent issue of Phytotherapy Research reveals Pycnogenol (pic-noj-en-all), an antioxidant plant extract from the bark of the French maritime pine tree, has important anti-inflammatory and anti-thrombotic properties that may be beneficial in patients with hemorrhoids, both for acute and chronic treatment, and in preventing new attacks.

"Topical medications, lifestyle changes and careful hygiene are all that is needed for most patients to control symptoms of hemorrhoids," said Professor Peter Rohdewald, a co-author of the study. "In this study, both topical and oral Pycnogenol treatment reduced the intensity and duration of hemorrhoidal pain and bleeding. Pycnogenol even reduced the number of procedures and hospital admissions caused by severe cases."

The randomized, controlled study conducted by G D'Annunzio University in Italy investigated 84 patients suffering from an acute episode of external hemorrhoids, lasting 24 to 48 hours prior to inclusion in the study. The most frequently observed signs and symptoms, including hemorrhoidal bleedings, severe perineal pain and intravascular thrombus, were evaluated during the study period of two weeks. Patients were randomly allocated to one of three treatment groups, as follows: Treatment of Group 1 consisted of initial 300 mg of Pycnogenol tablets daily for four days, followed by 150 mg per day for the following three days; Group 2 received the same treatment as Group 1, plus 0.5% Pycnogenol topical cream; and Group 3 was a placebo treatment group. Symptoms of hemorr
'/>"/>

Contact: Jamie Plaxco
jplaxco@mww.com
312-546-3512
MWW Group
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
2. A study by the MUHC and McGill University opens a new door to understanding cancer
3. Study begins to reveal clues to the cause and progression of sepsis
4. Clones on task serve greater good, evolutionary study shows
5. New study warns limited carbon market puts 20 percent of tropical forest at risk
6. New study examines how rearing environment can alter navigation
7. Study links cat disease to flame retardants in furniture and to pet food
8. New continent and species discovered in Atlantic study
9. Study shows link between alcohol consumption and hiv disease progression
10. Feeling hot, hot, hot: New study suggests ways to control fever-induced seizures
11. Study finds environmental tests help predict hospital-acquired Legionnaires disease risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... contribute to early fetal death according to a new ... Children,s Hospital Los Angeles and Ulaanbaatar, Mongolia the ... paper published today in the journal BMC Pregnancy ... between seasonal ambient air pollutants and pregnancy loss in ... the highest levels of air pollution of all world ...
(Date:4/23/2014)... Like a hungry diner ripping open a dinner roll, ... must tear open a hydrogen molecule. Now researchers have ... the two halves of its hydrogen feast. The view ... make the catalyst work better for alternative energy uses. ... shown precisely where the hydrogen halves end up in ...
(Date:4/23/2014)... research shows that male black widow spiders prefer their ... example of mate preference by male spiders. ... and Maydianne Andrade, a professor in UTSC,s Department of ... the wild that males overwhelmingly chose to mate with ... can tell whether a potential mate is well-fed and ...
Breaking Biology News(10 mins):Pollutants from coal-burning stoves strongly associated with miscarriages in Mongolia 2Halving hydrogen 2Halving hydrogen 3Halving hydrogen 4Picky male black widow spiders prefer well-fed virgins 2
... Nadeau, PhD, of Case Western Reserve University School of ... (NIH) Director,s Pioneer Award. One of 17 ... investigate transgenerational genetic effects, where the biological features and ... depend as much on the genetics of ancestral generations ...
... A 15-year experiment in an outdoor "laboratory" on Ohio ... just as many, if not more, ecological services as will ... been comparing the behavior of two experimental marshes on the ... and another that was left to colonize plant and animal ...
... in Spanish . A beneficial yeast that ... the fungal culprit behind Fusarium head blight ("scab"). U.S. ... isolated an improved variant of the yeast Cryptococcus flavescens ... as a biocontrol agent. In susceptible wheat and ...
Cached Biology News:Case Western Reserve geneticist receives prestigious NIH Director's Pioneer Award 2Planted, unplanted man-made wetlands are similar at year 15, and function as effective carbon sinks 2Planted, unplanted man-made wetlands are similar at year 15, and function as effective carbon sinks 3Planted, unplanted man-made wetlands are similar at year 15, and function as effective carbon sinks 4Flower-dwelling yeast licensed for use against scab disease 2
(Date:1/14/2014)... 14, 2014 EquitiesIQ, a leading informational ... ALQA). Alliqua is an emerging biomedical company acquiring, developing, ... care market. , Free report download: http://equitiesiq.com/reports/alliqua/ ... seasoned management team and Board, which launched the company’s ...
(Date:1/14/2014)... BETHESDA, Md. , Jan. 14, 2014  Organovo ... institutes from the National Institutes of Health (NIH) to ... more effective treatments to patients on a faster timeline. ... Translational Sciences (NCATS) and the National Eye Institute (NEI) ...
(Date:1/14/2014)... 2014 In recent years, growing suspicion ... in product development and promotion has led to unprecedented ... fueled by concerns about the insidious impact of commercialization ... spectacular fines to the world’s biggest pharmas for illegal ...
(Date:1/14/2014)... Rockville, MD (PRWEB) January 14, 2014 ... dedicated to developing innovative information technology solutions for ... other health care stakeholders, announced today the signing ... the US Food and Drug Administration (FDA). ...
Breaking Biology Technology:EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... loss is a major cause of death from roadside bombs ... for people age 4 to 44, often overwhelms the body,s ... natural process, a team led by Erin Lavik, a new ... doctoral student, James P. Bertram, built synthetic platelets that show ...
... Care at Hahnemann among the Best in the Nation ... it has been granted Magnet(R) recognition by the American Nurses ... the highest levels of recognition a hospital or medical center ... hospitals in the country that have achieved this prestigious distinction. ...
... , , , , WALTHAM, ... world,s leading research and advisory firms for pharmaceutical and ... dermatologists, Centocor Ortho Biotech/Janssen-Cilag,s Stelara and Abbott,s briakinumab (both ... share in 2012 in the drug market for moderate ...
Cached Biology Technology:Researchers take the inside route to halt bleeding 2Hahnemann University Hospital Granted Magnet(R) Status 2Hahnemann University Hospital Granted Magnet(R) Status 3In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 2In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 3